OpGen, Inc. (OPGN:NASDAQ) soared at $0.23, a gain of 84.8%. On Tue, Dec 13, 2022, OPGN:NASDAQ hit a New 2-Week High of $0.23. The stock appeared on our News Catalysts scanner on Tue, Dec 13, 2022 at 01:00 PM in the 'BIOTECH' category. From Tue, Nov 29, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Tue, Dec 13, 2022 at $0.45 with a volume of 239M+.
About OpGen, Inc. (OPGN:NASDAQ)
OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- OpGen, Inc. (OPGN:NASDAQ), 84.8%
- Vincerx Pharma Inc. (VINC:NASDAQ), 58.82%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 52.78%
- Shineco Inc. (SISI:NASDAQ), 49.23%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 43.8%
- Summit Therapeutics plc (SMMT:NASDAQ), 38.65%
- BeyondSpring Inc. (BYSI:NASDAQ), 35.94%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 33.83%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 32.69%